Structure/function studies of human decay-accelerating factor (Q28139971)

1

0 references

L Kuttner-Kondo

2

0 references

C Mold

3

0 references

M E Medof

Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases

4

0 references

language of work or name

English

0 references

publication date

September 2000

0 references

published in

Immunology

0 references

volume

101

0 references

issue

1

0 references

page(s)

104-11

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55)

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Sites within the complement C3b/C4b receptor important for the specificity of ligand binding

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327052

Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF)

2 June 2018

1 reference

12 December 2020

A fluorimetric assay for native C3. The hemolytically active form of the third component of human complement

1 reference

12 December 2020

Molecular modeling and mechanism of action of human decay-accelerating factor.

1 reference

12 December 2020

Use of recombinant DAF proteins to localize the epitopes recognized by monoclonal anti-CD55

1 reference

12 December 2020

Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function

1 reference

12 December 2020